pharma is the sole category represented across all 1 tracked stories. Of the tracked stories, 1 of 1 also mention Mereo BioPharma Group plc, the most common co-covered peer. Each carries 4 original sources on average. We currently track 1 Biotech story that mention Fermi Inc, all published on March 5, 2026.
Figures are computed live from our source-verified story record
— see our methodology for how impact and
sentiment are derived.
What the coverage shows about Fermi Inc
pharma is the sole category represented across all 1 tracked stories. Of the tracked stories, 1 of 1 also mention Mereo BioPharma Group plc, the most common co-covered peer. Each carries 4 original sources on average. We currently track 1 Biotech story that mention Fermi Inc, all published on March 5, 2026.
Stories tracked
1
Sources per story
4
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 13 Biotech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Appears alongside
Other entities that clear the same relevance threshold in stories also covering Fermi Inc. Shared-story counts are live from our verified record — not editorial picks.
Pomerantz Law Firm has issued urgent reminders to investors regarding class action deadlines for Ultragenyx, Mereo BioPharma, Navan, and Fermi. These legal actions follow allegations of misleading statements and failures to disclose material risks concerning clinical data and financial projections.
Fermi Inc is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source
link? Report a data issue.